CIM INVESTMENT MANAGEMENT INC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
CIM INVESTMENT MANAGEMENT INC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2020$287,000
-26.4%
7,716
+1.5%
0.11%
-30.6%
Q2 2020$390,000
+63.9%
7,604
+17.2%
0.16%
+76.4%
Q3 2019$238,000
-21.2%
6,4860.0%0.09%
-19.8%
Q2 2019$302,000
+5.2%
6,486
-9.2%
0.11%
+0.9%
Q1 2019$287,000
-13.3%
7,144
-0.8%
0.11%
-23.6%
Q4 2018$331,000
+3.4%
7,2050.0%0.14%
+26.3%
Q3 2018$320,000
+13.5%
7,2050.0%0.11%
+17.5%
Q2 2018$282,000
-45.9%
7,2050.0%0.10%
-45.2%
Q1 2018$521,000
+84.1%
7,205
+67.8%
0.18%
+82.5%
Q4 2017$283,000
+28.6%
4,294
-2.0%
0.10%
+21.2%
Q3 2017$220,000
-45.8%
4,381
-50.0%
0.08%
-44.4%
Q2 2017$406,000
+26.9%
8,768
-3.1%
0.14%
+30.9%
Q1 2017$320,000
+42.2%
9,050
-49.6%
0.11%
+34.1%
Q4 2016$225,000
-9.6%
17,9500.0%0.08%
-13.7%
Q3 2016$249,000
+45.6%
17,950
+3.9%
0.10%
+33.8%
Q2 2016$171,000
-35.0%
17,270
+11.1%
0.07%
-38.3%
Q1 2016$263,000
+20.6%
15,550
+482.6%
0.12%
+19.8%
Q2 2015$218,0002,6690.10%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2023
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders